Making better scar: Emerging approaches for modifying mechanical and electrical properties following infarction and ablation

Progress in Biophysics and Molecular Biology

Volumn 120, Issue 1-3, 2016, Pages 134-148

  Holmes, Jeffrey W ^a   Laksman, Zachary ^b   Gepstein, Lior ^c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Ablation; Atrial fibrillation; Cell therapy; Gene therapy; Myocardial infarction; Scar

Indexed keywords

ABLATION THERAPY; ANIMAL; ATRIAL FIBRILLATION; COMPLICATION; ELECTROPHYSIOLOGY; HUMAN; MECHANICS; MYOCARDIAL INFARCTION; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; SCAR;

ABLATION TECHNIQUES; ANIMALS; ATRIAL FIBRILLATION; CICATRIX; ELECTROPHYSIOLOGICAL PHENOMENA; HUMANS; MECHANICAL PHENOMENA; MYOCARDIAL INFARCTION;

EID: 84963669730     PISSN: 00796107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbiomolbio.2015.11.002     Document Type: Article

References (171)

1. Akaishi M., Weintraub W.S., Schneider R.M., Klein L.W., Agarwal J.B., Helfant R.H. Analysis of systolic bulging. Mechanical characteristics of acutely ischemic myocardium in the conscious dog. Circ. Res. 1986, 58:209-217. 10.1161/01.RES.58.2.209.
2. Alhogbani T.M., Strohm O., Matthias F. Evaluation of normal atrial contribution to left ventricular filling. J. Cardiovasc. Magn. Reson. 2010, 12:O91. 10.1186/1532-429X-12-S1-O91.
3. Andrade J., Khairy P., Dobrev D., Nattel S. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ. Res. 2014, 114:1453-1468. 10.1161/CIRCRESAHA.114.303211.
4. Andrade J.G., Rivard L., Macle L. The past, the present, and the future of cardiac arrhythmia ablation. Can. J. Cardiol. 2014, 30:S431-S441. 10.1016/j.cjca.2014.07.731.
5. Anné W., Willems R., Holemans P., Beckers F., Roskams T., Lenaerts I., Ector H., Heidbüchel H. Self-terminating AF depends on electrical remodeling while persistent AF depends on additional structural changes in a rapid atrially paced sheep model. J. Mol. Cell. Cardiol. 2007, 43:148-158. 10.1016/j.yjmcc.2007.05.010.
6. Antzelevitch C., Sicouri S., Litovsky S.H., Lukas A., Krishnan S.C., Di Diego J.M., Gintant G.A., Liu D.W. Heterogeneity within the ventricular wall. Electrophysiology and pharmacology of epicardial, endocardial, and M cells. Circ. Res. 1991, 69:1427-1449. 10.1161/01.RES.69.6.1427.
7. Bahnson T.D., Eyerly S.A., Hollender P.J., Doherty J.R., Kim Y.-J., Trahey G.E., Wolf P.D. Feasibility of near real-time lesion assessment during radiofrequency catheter ablation in humans using acoustic radiation force impulse imaging. J. Cardiovasc. Electrophysiol. 2014, 25:1275-1283. 10.1111/jce.12514.
8. Barandon L., Couffinhal T., Ezan J., Dufourcq P., Costet P., Alzieu P., Leroux L., Moreau C., Dare D., Duplàa C. Reduction of infarct size and prevention of cardiac rupture in transgenic mice overexpressing FrzA. Circulation 2003, 108:2282-2289. 10.1161/01.CIR.0000093186.22847.4C.
9. Bellini C., Di Martino E.S. A mechanical characterization of the porcine atria at the healthy stage and after ventricular tachypacing. J. Biomech. Eng. 2012, 134:021008. 10.1115/1.4006026.
10. Bellini C., Di Martino E.S., Federico S. Mechanical behaviour of the human atria. Ann. Biomed. Eng. 2013, 41:1478-1490. 10.1007/s10439-012-0699-9.
11. Bénitah J.P., Gomez A.M., Bailly P., Da Ponte J.P., Berson G., Delgado C., Lorente P. Heterogeneity of the early outward current in ventricular cells isolated from normal and hypertrophied rat hearts. J. Physiol. 1993, 469:111-138.
12. Benito B., Josephson M.E. Ventricular tachycardia in coronary artery disease. Rev. Esp. Cardiol. 2012, 65:939-955. 10.1016/j.recesp.2012.03.027.
13. Bhargava M., Di Biase L., Mohanty P., Prasad S., Martin D.O., Williams-Andrews M., Wazni O.M., Burkhardt J.D., Cummings J.E., Khaykin Y., Verma A., Hao S., Beheiry S., Hongo R., Rossillo A., Raviele A., Bonso A., Themistoclakis S., Stewart K., Saliba W.I., Schweikert R.A., Natale A. Impact of type of atrial fibrillation and repeat catheter ablation on long-term freedom from atrial fibrillation: results from a multicenter study. Heart Rhythm 2009, 6:1403-1412. 10.1016/j.hrthm.2009.06.014.
14. Bogen D.K., Rabinowitz S.A., Needleman A., McMahon T.A., Abelmann W.H. An analysis of the mechanical disadvantage of myocardial infarction in the canine left ventricle. Circ. Res. 1980, 47:728-741.
15. Boyd A.C., Schiller N.B., Leung D., Ross D.L., Thomas L. Atrial dilation and altered function are mediated by age and diastolic function but not before the eighth decade. JACC Cardiovasc. Imaging 2011, 4:234-242. 10.1016/j.jcmg.2010.11.018.
16. Boyden E.S., Zhang F., Bamberg E., Nagel G., Deisseroth K. Millisecond-timescale, genetically targeted optical control of neural activity. Nat. Neurosci. 2005, 8:1263-1268. 10.1038/nn1525.
17. Brown E.J., Kloner R.A., Schoen F.J., Hammerman H., Hale S., Braunwald E. Scar thinning due to ibuprofen administration after experimental myocardial infarction. Am. J. Cardiol. 1983, 51:877-883.
18. Bruegmann T., Malan D., Hesse M., Beiert T., Fuegemann C.J., Fleischmann B.K., Sasse P. Optogenetic control of heart muscle in vitro and in vivo. Nat. Methods 2010, 7:897-900. 10.1038/nmeth.1512.
19. Burton D.Y., Song C., Fishbein I., Hazelwood S., Li Q., DeFelice S., Connolly J.M., Perlstein I., Coulter D.A., Levy R.J. The incorporation of an ion channel gene mutation associated with the long QT syndrome (Q9E-hMiRP1) in a plasmid vector for site-specific arrhythmia gene therapy: in vitro and in vivo feasibility studies. Hum. Gene Ther. 2003, 14:907-922. 10.1089/104303403765701196.
20. Carlsson J., Miketic S., Windeler J., Cuneo A., Haun S., Micus S., Walter S., Tebbe U. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the strategies of treatment of atrial fibrillation (STAF) study. J. Am. Coll. Cardiol. 2003, 41:1690-1696. 10.1016/S0735-1097(03)00332-2.
21. Carmeliet E. Cardiac ionic currents and acute ischemia: from channels to arrhythmias. Physiol. Rev. 1999, 79:917-1017.
22. Casaclang-Verzosa G., Gersh B.J., Tsang T.S.M. Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation. J. Am. Coll. Cardiol. 2008, 51:1-11. 10.1016/j.jacc.2007.09.026.
23. Chang S.L., Tai C.T., Lin Y.J., Wongcharoen W., Lo L.W., Tuan T.C., Udyavar A.R., Chang S.H., Tsao H.M., Hsieh M.H., Hu Y.F., Chen Y.J., Chen S.A. Biatrial substrate properties in patients with atrial fibrillation. J. Cardiovasc. Electrophysiol. 2007, 18:1134-1139. 10.1111/j.1540-8167.2007.00941.x.
24. Chong J.J.H., Yang X., Don C.W., Minami E., Liu Y.-W., Weyers J.J., Mahoney W.M., Van Biber B., Cook S.M., Palpant N.J., Gantz J.A., Fugate J.A., Muskheli V., Gough G.M., Vogel K.W., Astley C.A., Hotchkiss C.E., Baldessari A., Pabon L., Reinecke H., Gill E.A., Nelson V., Kiem H.-P., Laflamme M.A., Murry C.E. Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature 2014, 510:273-277. 10.1038/nature13233.
25. Chugh S.S., Havmoeller R., Narayanan K., Singh D., Rienstra M., Benjamin E.J., Gillum R.F., Kim Y.H., McAnulty J.H., Zheng Z.J., Forouzanfar M.H., Naghavi M., Mensah G.A., Ezzati M., Murray C.J.L. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation 2014, 129:837-847. 10.1161/CIRCULATIONAHA.113.005119.
26. Clarke S.A., Goodman N.C., Ailawadi G., Holmes J.W. Effect of scar compaction on the therapeutic efficacy of anisotropic reinforcement following myocardial infarction in the dog. J. Cardiovasc. Transl. Res. 2015, 8:353-361. 10.1007/s12265-015-9637-1.
27. Cochet H., Scherr D., Zellerhoff S., Sacher F., Derval N., Denis A., Knecht S., Komatsu Y., Montaudon M., Laurent F., Pieske B.M., Hocini M., Haïssaguerre M., Jaïs P. Atrial structure and function 5 years after successful ablation for persistent atrial fibrillation: an MRI study. J. Cardiovasc. Electrophysiol. 2014, 25:671-679. 10.1111/jce.12449.
28. Czosek R.J., Bonney W.J., Cassedy A., Mah D.Y., Tanel R.E., Imundo J.R., Singh A.K., Cohen M.I., Miyake C.Y., Fawley K., Marino B.S. Impact of cardiac devices on the quality of life in pediatric patients. Circ. Arrhythmia Electrophysiol. 2012, 5:1064-1072. 10.1161/CIRCEP.112.973032.
29. De Bakker J.M., van Capelle F.J., Janse M.J., Tasseron S., Vermeulen J.T., de Jonge N., Lahpor J.R. Slow conduction in the infarcted human heart. "Zigzag" course of activation. Circulation 1993, 88:915-926. 10.1161/01.CIR.88.3.915.
30. De Bakker J.M., van Capelle F.J., Janse M.J., Wilde A.A., Coronel R., Becker A.E., Dingemans K.P., van Hemel N.M., Hauer R.N. Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation. Circulation 1988, 77:589-606. 10.1161/01.CIR.77.3.589.
31. Dillon S.M., Allessie M.A., Ursell P.C., Wit A.L. Influences of anisotropic tissue structure on reentrant circuits in the epicardial border zone of subacute canine infarcts. Circ. Res. 1988, 63:182-206. 10.1161/01.RES.63.1.182.
32. Donal E., Ollivier R., Veillard D., Hamonic S., Pavin D., Daubert J.-C., Mabo P. Left atrial function assessed by trans-thoracic echocardiography in patients treated by ablation for a lone paroxysmal atrial fibrillation. Eur. J. Echocardiogr. 2010, 11:845-852. 10.1093/ejechocard/jeq074.
33. Dorian P., Mangat I. Quality of life variables in the selection of rate versus rhythm control in patients with atrial fibrillation: observations from the Canadian trial of atrial Fibrillation. Card. Electrophysiol. Rev. 2003, 7:276-279. 10.1023/B:CEPR.0000012395.33292.cd.
34. Earley M.J., Schilling R.J. Catheter and surgical ablation of atrial fibrillation. Heart 2006, 92:266-274. 10.1136/hrt.2005.067389.
35. Echt D.S., Liebson P.R., Mitchell L.B., Peters R.W., Obias-Manno D., Barker A.H., Arensberg D., Baker A., Friedman L., Greene H.L. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial. N. Engl. J. Med. 1991, 324:781-788. 10.1056/NEJM199103213241201.
36. Everett T.H., Li H., Mangrum J.M., McRury I.D., Mitchell M.A., Redick J.A., Haines D.E. Electrical, morphological, and ultrastructural remodeling and reverse remodeling in a canine model of chronic atrial fibrillation. Circulation 2000, 102:1454-1460. 10.1161/01.CIR.102.12.1454.
37. Everett T.H., Wilson E.E., Verheule S., Guerra J.M., Foreman S., Olgin J.E. Structural atrial remodeling alters the substrate and spatiotemporal organization of atrial fibrillation: a comparison in canine models of structural and electrical atrial remodeling. Am. J. Physiol. Heart Circ. Physiol. 2006, 291:H2911-H2923. 10.1152/ajpheart.01128.2005.
38. Eyerly S.A., Vejdani-Jahromi M., Dumont D.M., Trahey G.E., Wolf P.D. The evolution of tissue stiffness at radiofrequency ablation sites during lesion formation and in the peri-ablation period. J. Cardiovasc. Electrophysiol. 2015, 26:1009-1018. 10.1111/jce.12709.
39. Feld Y., Melamed-Frank M., Kehat I., Tal D., Marom S., Gepstein L. Electrophysiological modulation of cardiomyocytic tissue by transfected fibroblasts expressing potassium channels: a novel strategy to manipulate excitability. Circulation 2002, 105:522-529. 10.1161/hc0402.102661.
40. Fomovsky G.M., Clark S.A., Parker K.M., Ailawadi G., Holmes J.W. Anisotropic reinforcement of acute anteroapical infarcts improves pump function. Circ. Hear. Fail. 2012, 5:515-522. 10.1161/CIRCHEARTFAILURE.111.965731.
41. Fomovsky G.M., Holmes J.W. Evolution of scar structure, mechanics, and ventricular function after myocardial infarction in the rat. Am. J. Physiol. Heart Circ. Physiol. 2010, 298:H221-H228. 10.1152/ajpheart.00495.2009.
42. Fomovsky G.M., Macadangdang J.R., Ailawadi G., Holmes J.W. Model-based design of mechanical therapies for myocardial infarction. J. Cardiovasc. Transl. Res. 2011, 4:82-91. 10.1007/s12265-010-9241-3.
43. Fomovsky G.M., Rouillard A.D., Holmes J.W. Regional mechanics determine collagen fiber structure in healing myocardial infarcts. J. Mol. Cell. Cardiol. 2012, 52:1083-1090. 10.1016/j.yjmcc.2012.02.012.
44. Gaita F., Caponi D., Scaglione M., Montefusco A., Corleto A., Di Monte F., Coin D., Di Donna P., Giustetto C. Long-term clinical results of 2 different ablation strategies in patients with paroxysmal and persistent atrial fibrillation. Circ. Arrhythm. Electrophysiol. 2008, 1:269-275. 10.1161/CIRCEP.108.774885.
45. Gao X.-M., White D.A., Dart A.M., Du X.-J. Post-infarct cardiac rupture: recent insights on pathogenesis and therapeutic interventions. Pharmacol. Ther. 2012, 134:156-179. 10.1016/j.pharmthera.2011.12.010.
46. Garan H., Stavens C.S., McGovern B., Kelly E., Ruskin J.N. Reproducibility of ventricular tachycardia suppression by antiarrhythmic drug therapy during serial electrophysiologic testing in coronary artery disease. Am. J. Cardiol. 1986, 58:977-980. 10.1016/S0002-9149(86)80022-4.
47. Gardner P.I., Ursell P.C., Fenoglio J.J., Wit A.L. Electrophysiologic and anatomic basis for fractionated electrograms recorded from healed myocardial infarcts. Circulation 1985, 72:596-611. 10.1161/01.CIR.72.3.596.
48. Gepstein L., Ding C., Rehemedula D., Wilson E.E., Yankelson L., Caspi O., Gepstein A., Huber I., Olgin J.E. In vivo assessment of the electrophysiological integration and arrhythmogenic risk of myocardial cell transplantation strategies. Stem Cells 2010, 28:2151-2161. 10.1002/stem.545.
49. Gould P., Krahn A. Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories. JAMA 2006, 295:1907-1911. 10.1001/jama.295.16.1907.
50. Greener I.D., Sasano T., Wan X., Igarashi T., Strom M., Rosenbaum D.S., Donahue J.K. Connexin43 gene transfer reduces ventricular tachycardia susceptibility after myocardial infarction. J. Am. Coll. Cardiol. 2012, 60:1103-1110. 10.1016/j.jacc.2012.04.042.
51. Guédon-Moreau L., Capucci A., Denjoy I., Morgan C.C., Périer A., Leplège A., Kacet S. Impact of the control of symptomatic paroxysmal atrial fibrillation on health-related quality of life. Europace 2010, 12:634-642. 10.1093/europace/euq007.
52. Guerra J.M., Everett T.H., Lee K.W., Wilson E., Olgin J.E. Effects of the gap junction modifier rotigaptide (ZP123) on atrial conduction and vulnerability to atrial fibrillation. Circulation 2006, 114:110-118. 10.1161/CIRCULATIONAHA.105.606251.
53. Gupta K.B., Ratcliffe M.B., Fallert M.A., Edmunds L.H., Bogen D.K. Changes in passive mechanical stiffness of myocardial tissue with aneurysm formation. Circulation 1994, 89:2315-2326. 10.1161/01.CIR.89.5.2315.
54. Habbab M.D.A., El-Sherif N. Drug-induced torsades de pointes: role of early afterdepolarizations and dispersion of repolarization. Am. J. Med. 1990, 89:241-246. 10.1016/0002-9343(90)90307-Y.
55. Haines D.E. Asymptomatic cerebral embolism and atrial fibrillation ablation: what price victory?. Circ. Arrhythmia Electrophysiol. 2013, 6:455-457. 10.1161/CIRCEP.113.000539.
56. Haïssaguerre M., Jaïs P., Shah D.C., Takahashi A., Hocini M., Quiniou G., Garrigue S., Le Mouroux A., Le Métayer P., Clémenty J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N. Engl. J. Med. 1998, 339:659-666. 10.1097/00045415-199903000-00006.
57. Halbach M., Peinkofer G., Baumgartner S., Maass M., Wiedey M., Neef K., Krausgrill B., Ladage D., Fatima A., Saric T., Hescheler J., Müller-Ehmsen J. Electrophysiological integration and action potential properties of transplanted cardiomyocytes derived from induced pluripotent stem cells. Cardiovasc. Res. 2013, 100:432-440. 10.1093/cvr/cvt213.
58. Hammerman H., Kloner R.A., Hale S., Schoen F.J., Braunwald E. Dose-dependent effects of short-term methylprednisolone on myocardial infarct extent, scar formation, and ventricular function. Circulation 1983, 68:446-452. 10.1161/01.CIR.68.2.446.
59. Hammerman H., Kloner R.A., Schoen F.J., Brown E.J., Hale S., Braunwald E. Indomethacin-induced scar thinning after experimental myocardial infarction. Circulation 1983, 67:1290-1295. 10.1161/01.CIR.67.6.1290.
60. Hennan J.K., Swillo R.E., Morgan G.A., Keith J.C., Schaub R.G., Smith R.P., Feldman H.S., Haugan K., Kantrowitz J., Wang P.J., Abu-Qare A., Butera J., Larsen B.D., Crandall D.L. Rotigaptide (ZP123) prevents spontaneous ventricular arrhythmias and reduces infarct size during myocardial ischemia/reperfusion injury in open-chest dogs. J. Pharmacol. Exp. Ther. 2006, 317:236-243. 10.1124/jpet.105.096933.Coronel.
61. Hocini M., Sanders P., Deisenhofer I., Jaïs P., Hsu L.F., Scavée C., Weerasoriya R., Raybaud F., Macle L., Shah D.C., Garrigue S., Le Metayer P., Clémenty J., Haïssaguerre M. Reverse remodeling of sinus node function after catheter ablation of atrial fibrillation in patients with prolonged sinus pauses. Circulation 2003, 108:1172-1175. 10.1161/01.CIR.0000090685.13169.07.
62. Hofshi A., Itzhaki I., Gepstein A., Arbel G., Gross G.J., Gepstein L. A combined gene and cell therapy approach for restoration of conduction. Heart Rhythm 2011, 8:121-130. 10.1016/j.hrthm.2010.10.011.
63. Hohnloser S.H., Kuck K.H., Lilienthal J. Rhythm or rate control in atrial fibrillation-Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial. Lancet 2000, 10.1016/S1062-1458(01)00270-7.
64. Holmes J.W., Borg T.K., Covell J.W. Structure and mechanics of healing myocardial infarcts. Annu. Rev. Biomed. Eng. 2005, 7:223-253. 10.1146/annurev.bioeng.7.060804.100453.
65. Holmes J.W., Nuñez J.A., Covell J.W. Functional implications of myocardial scar structure. Am. J. Physiol. 1997, 272:H2123-H2130.
66. Hoyt R.H., Cohen M.L., Corr P.B., Saffitz J.E. Alterations of intercellular junctions induced by hypoxia in canine myocardium. Am. J. Physiol. 1990, 258:H1439-H1448.
67. Hutchins G.M., Bulkley B.H. Infarct expansion versus extension: two different complications of acute myocardial infarction. Am. J. Cardiol. 1978, 41:1127-1132. 10.1016/0002-9149(78)90869-X.
68. Janse M.J., Wit A.L. Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction. Physiol. Rev. 1989, 69:1049-1169.
69. January C.T., Wann L.S., Alpert J.S., Calkins H., Cigarroa J.E., Cleveland J.C., Conti J.B., Ellinor P.T., Ezekowitz M.D., Field M.E., Murray K.T., Sacco R.L., Stevenson W.G., Tchou P.J., Tracy C.M., Yancy C.W., American College of Cardiology/American Heart Association Task Force on Practice Guidelines 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task Force on Practice Guidelines and the heart rhythm society. J. Am. Coll. Cardiol. 2014, 64:e1-76. 10.1016/j.jacc.2014.03.022.
70. Jeevanantham V., Ntim W., Navaneethan S.D., Shah S., Johnson A.C., Hall B., Shah A., Hundley W.G., Daubert J.P., Fitzgerald D. Meta-analysis of the effect of radiofrequency catheter ablation on left atrial size, volumes and function in patients with atrial fibrillation. Am. J. Cardiol. 2010, 105:1317-1326. 10.1016/j.amjcard.2009.12.046.
71. Jourda F., Providencia R., Marijon E., Bouzeman A., Hireche H., Khoueiry Z., Cardin C., Combes N., Combes S., Boveda S., Albenque J.-P. Contact-force guided radiofrequency vs. second-generation balloon cryotherapy for pulmonary vein isolation in patients with paroxysmal atrial fibrillation-a prospective evaluation. Europace 2015, 17:225-231. 10.1093/europace/euu215.
72. Jugdutt B.I. Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough?. Circulation 2003, 108:1395-1403. 10.1161/01.CIR.0000085658.98621.49.
73. Jugdutt B.I., Amy R.W.M. Healing after myocardial infarction in the dog: changes in infarct hydroxyproline and topography. J. Am. Coll. Cardiol. 1986, 7:91-102. 10.1016/S0735-1097(86)80265-0.
74. Kehat I., Khimovich L., Caspi O., Gepstein A., Shofti R., Arbel G., Huber I., Satin J., Itskovitz-Eldor J., Gepstein L. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat. Biotechnol. 2004, 22:1282-1289. 10.1038/nbt1014.
75. Kikuchi K., McDonald A.D., Sasano T., Donahue J.K. Targeted modification of atrial electrophysiology by homogeneous transmural atrial gene transfer. Circulation 2005, 111:264-270. 10.1161/01.CIR.0000153338.47507.83.
76. Kirkton R.D., Bursac N. Engineering biosynthetic excitable tissues from unexcitable cells for electrophysiological and cell therapy studies. Nat. Commun. 2011, 2:300. 10.1038/ncomms1302.
77. Kizana E., Chang C.Y., Cingolani E., Ramirez-Correa G.A., Sekar R.B., Abraham M.R., Ginn S.L., Tung L., Alexander I.E., Marbán E. Gene transfer of connexin43 mutants attenuates coupling in cardiomyocytes: novel basis for modulation of cardiac conduction by gene therapy. Circ. Res. 2007, 100:1597-1604. 10.1161/CIRCRESAHA.106.144956.
78. Klein G.J., Harrison L., Ideker R.F., Smith W.M., Kasell J., Wallace A.G., Gallagher J.J. Reaction of the myocardium to cryosurgery: electrophysiology and arrhythmogenic potential. Circulation 1979, 59:364-372. 10.1161/01.CIR.59.2.364.
79. Kobayashi K., Luo M., Zhang Y., Wilkes D.C., Ge G., Grieskamp T., Yamada C., Liu T.-C., Huang G., Basson C.T., Kispert A., Greenspan D.S., Sato T.N. Secreted Frizzled-related protein 2 is a procollagen C proteinase enhancer with a role in fibrosis associated with myocardial infarction. Nat. Cell Biol. 2009, 11:46-55. 10.1038/ncb1811.
80. Kojodjojo P., Peters N.S., Davies D.W., Kanagaratnam P. Characterization of the electroanatomical substrate in human atrial fibrillation: the relationship between changes in atrial volume, refractoriness, wavefront propagation velocities, and AF burden. J. Cardiovasc. Electrophysiol. 2007, 18:269-275. 10.1111/j.1540-8167.2007.00723.x.
81. Kuklik P., Molaee P., Podziemski P., Ganesan A.N., Brooks A.G., Worthley S.G., Sanders P. Quantitative description of the 3D regional mechanics of the left atrium using cardiac magnetic resonance imaging. Physiol. Meas. 2014, 35:763-775. 10.1088/0967-3334/35/5/763.
82. Kwiecinski W., Provost J., Dubois R., Sacher F., Haïssaguerre M., Legros M., Nguyen-Dinh A., Dufait R., Tanter M., Pernot M. Quantitative evaluation of atrial radio frequency ablation using intracardiac shear-wave elastography. Med. Phys. 2014, 41:112901. 10.1118/1.4896820.
83. Laeremans H., Hackeng T.M., van Zandvoort M.A.M.J., Thijssen V.L.J.L., Janssen B.J.A., Ottenheijm H.C.J., Smits J.F.M., Blankesteijn W.M. Blocking of frizzled signaling with a homologous peptide fragment of wnt3a/wnt5a reduces infarct expansion and prevents the development of heart failure after myocardial infarction. Circulation 2011, 124:1626-1635. 10.1161/CIRCULATIONAHA.110.976969.
84. Lafuente-Lafuente C., Mouly S., Longas-Tejero M.A., Bergmann J.F. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. Cochrane Database Syst. Rev. 2007, 10.1002/14651858.CD005049.pub2.
85. Landa N., Miller L., Feinberg M.S., Holbova R., Shachar M., Freeman I., Cohen S., Leor J. Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation 2008, 117:1388-1396. 10.1161/CIRCULATIONAHA.107.727420.
86. Lang C.N., Menza M., Jochem S., Franke G., Perez Feliz S., Brunner M., Koren G., Zehender M., Bugger H., Jung B.A., Foell D., Bode C., Odening K.E. Electro-mechanical dysfunction in long QT syndrome: role for arrhythmogenic risk prediction and modulation by sex and sex hormones. Prog. Biophys. Mol. Biol. 2016, 120(1-3):255-269.
87. Lau D.H., Clausen C., Sosunov E.A., Shlapakova I.N., Anyukhovsky E.P., Danilo P., Rosen T.S., Kelly C., Duffy H.S., Szabolcs M.J., Chen M., Robinson R.B., Lu J., Kumari S., Cohen I.S., Rosen M.R. Epicardial border zone overexpression of skeletal muscle sodium channel SkM1 normalizes activation, preserves conduction, and suppresses ventricular arrhythmia an in silico, in vivo, in vitro study. Circulation 2009, 119:19-27. 10.1161/CIRCULATIONAHA.108.809301.
88. Lazzara R., Scherlag B.J. Mechanisms of monomorphic ventricular tachycardia in coronary artery disease. J. Interv. Card. Electrophysiol. 2003, 8:87-92. 10.1023/A:1023651231389.
89. Leor J., Tuvia S., Guetta V., Manczur F., Castel D., Willenz U., Petneházy O., Landa N., Feinberg M.S., Konen E., Goitein O., Tsur-Gang O., Shaul M., Klapper L., Cohen S. Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in swine. J. Am. Coll. Cardiol. 2009, 54:1014-1023. 10.1016/j.jacc.2009.06.010.
90. Li J.S., Zhong J.Q., Zeng Q.X., Liu H.Z., Su G.Y., Zhang Y. Effect of ZP123, a gap junction modifier, on prolonged ventricular fibrillation in swine. Cardiology 2011, 118:147-152. 10.1159/000328016.
91. Lloyd-Jones D.M., Wang T.J., Leip E.P., Larson M.G., Levy D., Vasan R.S., D'Agostino R.B., Massaro J.M., Beiser A., Wolf P.A., Benjamin E.J. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 2004, 110:1042-1046. 10.1161/01.CIR.0000140263.20897.42.
92. Lo L.W., Tai C.T., Lin Y.J., Chang S.L., Wongcharoen W., Chen S.A. Reverse atrial electrical remodeling after catheter ablation of persistent atrial fibrillation. J. Cardiovasc. Electrophysiol. 2006, 17:798-799. 10.1111/j.1540-8167.2006.00470.x.
93. Lue W.M., Boyden P.A. Abnormal electrical properties of myocytes from chronically infarcted canine heart. Alterations in Vmax and the transient outward current. Circulation 1992, 85:1175-1188. 10.1161/01.CIR.85.3.1175.
94. Macle L., Jaïs P., Weerasooriya R., Hocini M., Shah D.C., Choi K.-J., Scavée C., Raybaud F., Clémenty J., Haïssaguerre M. Irrigated-tip catheter ablation of pulmonary veins for treatment of atrial fibrillation. J. Cardiovasc. Electrophysiol. 2002, 13:1067-1073.
95. Macle L., Khairy P., Weerasooriya R., Novak P., Verma A., Willems S., Arentz T., Deisenhofer I., Veenhuyzen G., Scavée C., Jaïs P., Puererfellner H., Levesque S., Andrade J.G., Rivard L., Guerra P.G., Dubuc M., Thibault B., Talajic M., Roy D., Nattel S., ADVICE trial investigators Adenosine-guided pulmonary vein isolation for the treatment of paroxysmal atrial fibrillation: an international, multicentre, randomised superiority trial. Lancet (London, Engl.) 2015, 386:672-679. 10.1016/S0140-6736(15)60026-5.
96. Mahoney V., Mezzano V., Morley G.E. A review of the literature on cardiac electrical activity between fibroblasts and myocytes. Prog. Biophys. Mol. Biol. 2016, 120(1-3):128-133.
97. Mannisi J.A., Weisman H.F., Bush D.E., Dudeck P., Healy B. Steroid administration after myocardial infarction promotes early infarct expansion. A study in the rat. J. Clin. Invest. 1987, 79:1431-1439. 10.1172/JCI112971.
98. Mao J., Yin X., Zhang Y., Yan Q., Dong J., Ma C., Liu X. Ablation of epicardial ganglionated plexi increases atrial vulnerability to arrhythmias in dogs. Circ. Arrhythm. Electrophysiol. 2014, 7:711-717. 10.1161/CIRCEP.113.000799.
99. Marom S., Levitan I.B. State-dependent inactivation of the Kv3 potassium channel. Biophys. J. 1994, 67:579-589. 10.1016/S0006-3495(94)80517-X.
100. Mary-Rabine L., Albert A., Pham T.D., Hordof A., Fenoglio J.J., Malm J.R., Rosen M.R. The relationship of human atrial cellular electrophysiology to clinical function and ultrastructure. Circ. Res. 1983, 52:188-199. 10.1161/01.RES.52.2.188.
101. Masci P.G., Ganame J., Francone M., Desmet W., Lorenzoni V., Iacucci I., Barison A., Carbone I., Lombardi M., Agati L., Janssens S., Bogaert J. Relationship between location and size of myocardial infarction and their reciprocal influences on post-infarction left ventricular remodelling. Eur. Heart J. 2011, 32:1640-1648. 10.1093/eurheartj/ehr064.
102. McGarvey J.R., Mojsejenko D., Dorsey S.M., Nikou A., Burdick J.A., Gorman J.H., Jackson B.M., Pilla J.J., Gorman R.C., Wenk J.F. Temporal changes in infarct material properties: an in vivo assessment using magnetic resonance imaging and finite element simulations. Ann. Thorac. Surg. 2015, 10.1016/j.athoracsur.2015.03.015.
103. McManus D.D., Rienstra M., Benjamin E.J. An update on the prognosis of patients with atrial fibrillation. Circulation 2012, 126:e143-e146. 10.1161/CIRCULATIONAHA.112.129759.
104. Medi C., Sparks P.B., Morton J.B., Kistler P.M., Halloran K., Rosso R., Vohra J.K., Kumar S., Kalman J.M. Pulmonary vein antral isolation for paroxysmal atrial fibrillation: results from long-term follow-up. J. Cardiovasc. Electrophysiol. 2011, 22:137-141. 10.1111/j.1540-8167.2010.01885.x.
105. Menasché P., Hagège A.A., Vilquin J.-T., Desnos M., Abergel E., Pouzet B., Bel A., Sarateanu S., Scorsin M., Schwartz K., Bruneval P., Benbunan M., Marolleau J.-P., Duboc D. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J. Am. Coll. Cardiol. 2003, 41:1078-1083. 10.1016/S0735-1097(03)00092-5.
106. Miller J.M., Kowal R.C., Swarup V., Daubert J.P., Daoud E.G., Day J.D., Ellenbogen K.A., Hummel J.D., Baykaner T., Krummen D.E., Narayan S.M., Reddy V.Y., Shivkumar K., Steinberg J.S., Wheelan K.R. Initial independent outcomes from focal impulse and rotor modulation ablation for atrial fibrillation: multicenter FIRM registry. J. Cardiovasc. Electrophysiol. 2014, 10.1111/jce.12474.
107. Miyauchi Y., Zhou S., Okuyama Y., Miyauchi M., Hayashi H., Hamabe A., Fishbein M.C., Mandel W.J., Chen L.S., Chen P.S., Karagueuzian H.S. Altered atrial electrical restitution and heterogeneous sympathetic hyperinnervation in hearts with chronic left ventricular myocardial infarction: implications for atrial fibrillation. Circulation 2003, 108:360-366. 10.1161/01.CIR.0000080327.32573.7C.
108. Morillo C.A., Klein G.J., Jones D.L., Guiraudon C.M. Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation 1995, 91:1588-1595. 10.1161/01.CIR.91.5.1588.
109. Moyer C.B. Mechanical Function of the Left Atrium 2013, (PhD Dissertation), University of Virginia.
110. Moyer C.B., Helm P.A., Clarke C.J., Budge L.P., Kramer C.M., Ferguson J.D., Norton P.T., Holmes J.W. Wall-motion based analysis of global and regional left atrial mechanics. IEEE Trans. Med. Imaging 2013, 32:1765-1776. 10.1109/TMI.2013.2264062.
111. Moyer C.B., Norton P.T., Ferguson J.D., Holmes J.W. Changes in global and regional mechanics due to atrial fibrillation: insights from a coupled finite-element and circulation model. Ann. Biomed. Eng. 2015, 43:1600-1613. 10.1007/s10439-015-1256-0.
112. Nagel G., Szellas T., Huhn W., Kateriya S., Adeishvili N., Berthold P., Ollig D., Hegemann P., Bamberg E. Channelrhodopsin-2, a directly light-gated cation-selective membrane channel. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:13940-13945. 10.1073/pnas.1936192100.
113. Narayan S.M., Baykaner T., Clopton P., Schricker A., Lalani G.G., Krummen D.E., Shivkumar K., Miller J.M. Ablation of rotor and focal sources reduces late recurrence of atrial fibrillation compared with trigger ablation alone: extended follow-up of the CONFIRM trial (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation). J. Am. Coll. Cardiol. 2014, 63:1761-1768. 10.1016/j.jacc.2014.02.543.
114. Neuzil P., Reddy V.Y., Kautzner J., Petru J., Wichterle D., Shah D., Lambert H., Yulzari A., Wissner E., Kuck K.H. Electrical reconnection after pulmonary vein isolation is contingent on contact force during initial treatment: results from the EFFICAS I study. Circ. Arrhythmia Electrophysiol. 2013, 6:327-333. 10.1161/CIRCEP.113.000374.
115. Nishida K., Datino T., Macle L., Nattel S. Atrial fibrillation ablation: translating basic mechanistic insights to the patient. J. Am. Coll. Cardiol. 2014, 65:560-569. 10.1016/j.jacc.2014.06.1172.
116. Nori D., Raff G., Gupta V., Gentry R., Boura J., Haines D.E. Cardiac magnetic resonance imaging assessment of regional and global left atrial function before and after catheter ablation for atrial fibrillation. J. Interv. Card. Electrophysiol. 2009, 26:109-117. 10.1007/s10840-009-9409-4.
117. Nussinovitch U., Gepstein L. Optogenetics for in vivo cardiac pacing and resynchronization. Nat. Biotechnol. 2015, 33:750-754. 10.1038/nbt.3268.
118. Nussinovitch U., Gepstein L. Optogenetics for suppression of cardiac electrical activity in human and rat cardiomyocyte cultures. Neurophotonics 2015, 2:031204. 10.1117/1.NPh.2.3.031204.
119. Nussinovitch U., Shinnawi R., Gepstein L. Modulation of cardiac tissue electrophysiological properties with light-sensitive proteins. Cardiovasc. Res. 2014, 102:176-187. 10.1093/cvr/cvu037.
120. O'Donnell D., Bourke J.P., Anilkumar R., Simeonidou E., Furniss S.S. Radiofrequency ablation for post infarction ventricular tachycardia. Report of a single centre experience of 112 cases. Eur. Heart J. 2002, 23:1699-1705. 10.1053/euhj.2001.3230.
121. Opie L.H., Coetzee W.A. Role of calcium ions in reperfusion arrhythmias: relevance to pharmacologic intervention. Cardiovasc. Drugs Ther. 1988, 2:623-636. 10.1007/BF00054202.
122. Opolski G., Torbicki A., Kosior D.A., Szulc M., Wozakowska-Kapłon B., Kołodziej P., Achremczyk P. Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) study. Chest 2004, 126:476-486. 10.1378/chest.126.2.476.
123. Ouyang F., Tilz R., Chun J., Schmidt B., Wissner E., Zerm T., Neven K., Köktürk B., Konstantinidou M., Metzner A., Fuernkranz A., Kuck K.H. Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5-year follow-up. Circulation 2010, 122:2368-2377. 10.1161/CIRCULATIONAHA.110.946806.
124. Pappone C., Rosanio S., Augello G., Gallus G., Vicedomini G., Mazzone P., Gulletta S., Gugliotta F., Pappone A., Santinelli V., Tortoriello V., Sala S., Zangrillo A., Crescenzi G., Benussi S., Alfieri O. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. J. Am. Coll. Cardiol. 2003, 42:185-197. 10.1016/S0735-1097(03)00577-1.
125. Peters N.S., Coromilas J., Severs N.J., Wit A.L. Disturbed connexin43 gap junction distribution correlates with the location of reentrant circuits in the epicardial border zone of healing canine infarcts that cause ventricular tachycardia. Circulation 1997, 95:988-996. 10.1161/01.CIR.95.4.988.
126. Pfeffer M.A., Pfeffer J.M., Fishbein M.C., Fletcher P.J., Spadaro J., Kloner R.A., Braunwald E. Myocardial infarct size and ventricular function in rats. Circ. Res. 1979, 44:503-512.
127. Pirzada F.A., Ekong E.A., Vokonas P.S., Apstein C.S., Hood W.B. Experimental myocardial infarction. XIII. Sequential changes in left ventricular pressure-length relationships in the acute phase. Circulation 1976, 53:970-975. 10.1161/01.CIR.53.6.970.
128. Pu J., Boyden P.A. Alterations of Na+ currents in myocytes from epicardial border zone of the infarcted heart. A possible ionic mechanism for reduced excitability and postrepolarization refractoriness. Circ. Res. 1997, 81:110-119. 10.1161/01.RES.81.1.110.
129. Qian L., Huang Y., Spencer C.I., Foley A., Vedantham V., Liu L., Conway S.J., Fu J., Srivastava D. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 2012, 485:593-598. 10.1038/nature11044.
130. Qin D., Zhang Z.H., Caref E.B., Boutjdir M., Jain P., El-Sherif N. Cellular and ionic basis of arrhythmias in postinfarction remodeled ventricular myocardium. Circ. Res. 1996, 79:461-473. 10.1161/01.RES.79.3.461.
131. Reddy V.Y., Shah D., Kautzner J., Schmidt B., Saoudi N., Herrera C., Jaïs P., Hindricks G., Peichl P., Yulzari A., Lambert H., Neuzil P., Natale A., Kuck K.H. The relationship between contact force and clinical outcome during radiofrequency catheter ablation of atrial fibrillation in the TOCCATA study. Heart Rhythm 2012, 9:1789-1795. 10.1016/j.hrthm.2012.07.016.
132. Richardson W.J., Clarke S.A., Holmes J.W. Physiological implications of myocardial scar structure. Compr. Physiol. 2015, 5:1877-1909.
133. Richardson W.J., Holmes J.W. Why is infarct expansion such an elusive therapeutic target?. J. Cardiovasc. Transl. Res. 2015, 8:421-430.
134. Roberts R., DeMello V., Sobel B.E. Deleterious effects of methylprednisolone in patients with myocardial infarction. Circulation 1976, 53:I204-I206.
135. Roell W., Lewalter T., Sasse P., Tallini Y.N., Choi B.-R., Breitbach M., Doran R., Becher U.M., Hwang S.-M., Bostani T., von Maltzahn J., Hofmann A., Reining S., Eiberger B., Gabris B., Pfeifer A., Welz A., Willecke K., Salama G., Schrickel J.W., Kotlikoff M.I., Fleischmann B.K., Figures S. Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature 2007, 450:819-824. 10.1038/nature06321.
136. Rouillard A.D., Holmes J.W. Mechanical regulation of fibroblast migration and collagen remodelling in healing myocardial infarcts. J. Physiol. 2012, 590:4585-4602. 10.1113/jphysiol.2012.229484.
137. Rubart M., Pasumarthi K.B.S., Nakajima H., Soonpaa M.H., Nakajima H.O., Field L.J. Physiological coupling of donor and host cardiomyocytes after cellular transplantation. Circ. Res. 2003, 92:1217-1224. 10.1161/01.RES.0000075089.39335.8C.
138. Ryan L.P., Matsuzaki K., Noma M., Jackson B.M., Eperjesi T.J., Plappert T.J., St John-Sutton M.G., Gorman J.H., Gorman R.C. Dermal filler injection: a novel approach for limiting infarct expansion. Ann. Thorac. Surg. 2009, 87:148-155. 10.1016/j.athoracsur.2008.09.028.
139. Santangeli P., Di Biase L., Natale A. Ablation versus drugs: what is the best first-line therapy for paroxysmal atrial fibrillation? Antiarrhythmic drugs are outmoded and catheter ablation should be the first-line option for all patients with paroxysmal atrial fibrillation: pro. Circ. Arrhythm. Electrophysiol. 2014, 7:739-746. 10.1161/CIRCEP.113.000629.
140. Sasano T., McDonald A.D., Kikuchi K., Donahue J.K. Molecular ablation of ventricular tachycardia after myocardial infarction. Nat. Med. 2006, 12:1256-1258. 10.1038/nm1503.
141. Sato S., Ashraf M., Millard R.W., Fujiwara H., Schwartz A. Connective tissue changes in early ischemia of porcine myocardium: an ultrastructural study. J. Mol. Cell. Cardiol. 1983, 15:261-275.
142. Shiba Y., Fernandes S., Zhu W.-Z., Filice D., Muskheli V., Kim J., Palpant N.J., Gantz J., Moyes K.W., Reinecke H., Van Biber B., Dardas T., Mignone J.L., Izawa A., Hanna R., Viswanathan M., Gold J.D., Kotlikoff M.I., Sarvazyan N., Kay M.W., Murry C.E., Laflamme M.A. Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature 2012, 489:322-325. 10.1038/nature11317.
143. Singh S.N., Fletcher R.D., Fisher S.G., Singh B.N., Lewis H.D., Deedwania P.C., Massie B.M., Colling C., Lazzeri D. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival trial of antiarrhythmic therapy in congestive heart failure. N. Engl. J. Med. 1995, 10.1056/NEJM199507133330201.
144. Singh S.N., Tang X.C., Singh B.N., Dorian P., Reda D.J., Harris C.L., Fletcher R.D., Sharma S.C., Atwood J.E., Jacobson A.K., Lewis H.D., Lopez B., Raisch D.W., Ezekowitz M.D. Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation. A veterans affairs cooperative studies program substudy. J. Am. Coll. Cardiol. 2006, 48:721-730. 10.1016/j.jacc.2006.03.051.
145. Skanes A.C., Yee R., Krahn A.D., Klein G.J. Cryoablation of atrial arrhythmias. Card. Electrophysiol. Rev. 2002, 6:383-388. 10.1023/A:1021128207078.
146. Solti F., Vecsey T., Kékesi V., Juhász-Nagy A. The effect of atrial dilatation on the genesis of atrial arrhythmias. Cardiovasc. Res. 1989, 23:882-886.
147. Song K., Nam Y.-J., Luo X., Qi X., Tan W., Huang G.N., Acharya A., Smith C.L., Tallquist M.D., Neilson E.G., Hill J.A., Bassel-Duby R., Olson E.N. Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature 2012, 485:599-604. 10.1038/nature11139.
148. Spencer K.T., Mor-Avi V., Gorcsan J., DeMaria A.N., Kimball T.R., Monaghan M.J., Perez J.E., Weinert L., Bednarz J., Edelman K., Kwan O.L., Glascock B., Hancock J., Baumann C., Lang R.M. Effects of aging on left atrial reservoir, conduit, and booster pump function: a multi-institution acoustic quantification study. Heart 2001, 85:272-277. 10.1136/heart.85.3.272.
149. Sunagawa K., Maughan W.L., Sagawa K. Effect of regional ischemia on the left ventricular end-systolic pressure-volume relationship of isolated canine hearts. Circ. Res. 1983, 52:170-178.
150. Takahashi S., Barry A., Factor S. Collagen degradation in ischaemic rat hearts. Biochem. J. 1990, 265:233-241.
151. Tennant R., Wiggers C.J. The effect of coronary occlusion on myocardial contraction. Am. J. Physiol. 1935, 112:351-361.
152. Thollon C., Kreher P., Charlon V., Rossi A. Hypertrophy induced alteration of action potential and effects of the inhibition of angiotensin converting enzyme by perindopril in infarcted rat hearts. Cardiovasc. Res. 1989, 23:224-230.
153. Thomas L., Boyd A., Thomas S.P., Schiller N.B., Ross D.L. Atrial structural remodelling and restoration of atrial contraction after linear ablation for atrial fibrillation. Eur. Heart J. 2003, 24:1942-1951. 10.1016/j.ehj.2003.08.018.
154. Tyberg J.V., Forrester J.S., Wyatt H.L., Goldner S.J., Parmley W.W., Swan H.J. An analysis of segmental ischemic dysfunction utilizing the pressure-length loop. Circulation 1974, 49:748-754. 10.1161/01.CIR.49.4.748.
155. Tzou W.S., Marchlinski F.E., Zado E.S., Lin D., Dixit S., Callans D.J., Cooper J.M., Bala R., Garcia F., Hutchinson M.D., Riley M.P., Verdino R., Gerstenfeld E.P. Long-term outcome after successful catheter ablation of atrial fibrillation. Circ. Arrhythmia Electrophysiol. 2010, 3:237-242. 10.1161/CIRCEP.109.923771.
156. Van den Borne S.W.M., van de Schans V.A.M., Strzelecka A.E., Vervoort-Peters H.T.M., Lijnen P.M., Cleutjens J.P.M., Smits J.F.M., Daemen M.J.A.P., Janssen B.J.A., Blankesteijn W.M. Mouse strain determines the outcome of wound healing after myocardial infarction. Cardiovasc. Res. 2009, 84:273-282. 10.1093/cvr/cvp207.
157. Van Gelder I.C., Hagens V.E., Bosker H.A., Kingma J.H., Kamp O., Kingma T., Said S.A., Darmanata J.I., Timmermans A.J.M., Tijssen J.G.P., Crijns H.J.G.M. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N. Engl. J. Med. 2002, 10.1056/NEJMoa021375.
158. Vianna-Pinton R., Moreno C.A., Baxter C.M., Lee K.S., Tsang T.S.M., Appleton C.P. Two-dimensional speckle-tracking echocardiography of the left atrium: feasibility and regional contraction and relaxation differences in normal subjects. J. Am. Soc. Echocardiogr. 2009, 22:299-305. 10.1016/j.echo.2008.12.017.
159. Vokonas P.S., Pirzada F., Hood W.B. Experimental myocardial infarction: XII. Dynamic changes in segmental mechanical behavior of infarcted and non-infarcted myocardium. Am. J. Cardiol. 1976, 37:853-859.
160. Wall S.T., Walker J.C., Healy K.E., Ratcliffe M.B., Guccione J.M. Theoretical impact of the injection of material into the myocardium: a finite element model simulation. Circulation 2006, 114:2627-2635. 10.1161/CIRCULATIONAHA.106.657270.
161. Wang X., Zhang M., Zhang Y., Xie X., Wang W., Li Z., Gao M., Wang Z., Hou Y. Long-term effects of ganglionated plexi ablation on electrophysiological characteristics and neuron remodeling in target atrial tissues in a canine model. Circ. Arrhythm. Electrophysiol. 2015, 10.1161/CIRCEP.114.002554.
162. White H.D., Chew D.P. Acute myocardial infarction. Lancet 2008, 372:570-584. 10.1016/S0140-6736(08)61237-4.
163. Wijffels M.C., Kirchhof C.J., Dorland R., Allessie M.A. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995, 92:1954-1968. 10.1161/01.CIR.92.7.1954.
164. Wright M., Narayan S.M. Ablation of atrial fibrillation. Trends Cardiovasc. Med. 2015, 25:409-419. 10.1016/j.tcm.2014.11.009.
165. Wyse D.G., Waldo A.L., DiMarco J.P., Domanski M.J., Rosenberg Y., Schron E.B., Kellen J.C., Greene H.L., Mickel M.C., Dalquist J.E., Corley S.D. A comparison of rate control and rhythm control in patients with atrial fibrillation. N. Engl. J. Med. 2002, 10.1056/NEJMoa021328.
166. Xiong B., Li D., Wang J., Gyawali L., Jing J., Su L. The effect of catheter ablation on left atrial size and function for patients with atrial fibrillation: an updated meta-analysis. PLoS One 2015, 10:e0129274. 10.1371/journal.pone.0129274.
167. Yang B., Lin H., Xiao J., Lu Y., Luo X., Li B., Zhang Y., Xu C., Bai Y., Wang H., Chen G., Wang Z. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat. Med. 2007, 13:486-491. 10.1038/nm1569.
168. Yankelson L., Feld Y., Bressler-Stramer T., Itzhaki I., Huber I., Gepstein A., Aronson D., Marom S., Gepstein L. Cell therapy for modification of the myocardial electrophysiological substrate. Circulation 2008, 117:720-731. 10.1161/CIRCULATIONAHA.106.671776.
169. Yu W.C., Lee S.H., Tai C.T., Tsai C.F., Hsieh M.H., Chen C.C., Ding Y.A., Chang M.S., Chen S.A. Reversal of atrial electrical remodeling following cardioversion of long-standing atrial fibrillation in man. Cardiovasc. Res. 1999, 42:470-476. 10.1016/S0008-6363(99)00030-9.
170. Zamilpa R., Lindsey M.L. Extracellular matrix turnover and signaling during cardiac remodeling following MI: causes and consequences. J. Mol. Cell. Cardiol. 2010, 48:558-563. 10.1016/j.yjmcc.2009.06.012.
171. Zimmer H.G., Gerdes A.M., Lortet S., Mall G. Changes in heart function and cardiac cell size in rats with chronic myocardial infarction. J. Mol. Cell. Cardiol. 1990, 22:1231-1243.